The Cerb-B2 positivity rate significantly decreased in the COVID-19 Era group, although this did not reach statistical significance ( p = 0.072).
← all excerpts
Effect of the COVID-19 Pandemic on the Management of Breast Cancer Patients.
1
0.0720
0.0720